Title |
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes From the Randomized BIOFLOW V Trial
|
---|---|
Published in |
JACC: Cardiovascular Interventions, June 2020
|
DOI | 10.1016/j.jcin.2020.02.019 |
Pubmed ID | |
Authors |
David E. Kandzari, Jacques J. Koolen, Gheorghe Doros, Hector M. Garcia-Garcia, Johan Bennett, Ariel Roguin, Elie G. Gharib, Donald E. Cutlip, Ron Waksman, BIOFLOW V Investigators |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 30% |
Germany | 3 | 11% |
Spain | 2 | 7% |
Argentina | 1 | 4% |
Italy | 1 | 4% |
Turkey | 1 | 4% |
France | 1 | 4% |
Pakistan | 1 | 4% |
Colombia | 1 | 4% |
Other | 2 | 7% |
Unknown | 6 | 22% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 21 | 78% |
Practitioners (doctors, other healthcare professionals) | 3 | 11% |
Science communicators (journalists, bloggers, editors) | 3 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 66 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 17% |
Student > Postgraduate | 5 | 8% |
Student > Doctoral Student | 4 | 6% |
Student > Bachelor | 4 | 6% |
Student > Ph. D. Student | 3 | 5% |
Other | 8 | 12% |
Unknown | 31 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 32% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Neuroscience | 2 | 3% |
Materials Science | 2 | 3% |
Agricultural and Biological Sciences | 1 | 2% |
Other | 5 | 8% |
Unknown | 33 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 343. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2022.
All research outputs
#95,551
of 25,387,668 outputs
Outputs from JACC: Cardiovascular Interventions
#7
of 4,033 outputs
Outputs of similar age
#3,618
of 433,033 outputs
Outputs of similar age from JACC: Cardiovascular Interventions
#2
of 147 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,033 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,033 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.